Tumour microenvironment and pituitary tumour behaviour

被引:11
|
作者
Marques, P. [1 ,2 ]
Korbonits, M. [3 ]
机构
[1] Hosp CUF Descobertas, Endocrinol Dept, Pituitary Tumor Unit, Lisbon, Portugal
[2] Univ Catolica Portuguesa, Fac Med, Lisbon, Portugal
[3] Queen Mary Univ London, William Harvey Res Inst, Ctr Endocrinol, Barts & London Sch Med & Dent, London, England
关键词
Pituitary tumour; Tumour microenvironment; Immune cell; Stromal cell; Fibroblast; Cytokine; Chemokine; Angiogenesis; Epithelial-to-mesenchymal transition; Immunotherapy; FOLLICULO-STELLATE CELLS; CANCER-ASSOCIATED FIBROBLASTS; GROWTH-HORMONE RELEASE; ADENOMAS RELATIONSHIP; EXTRACELLULAR-MATRIX; PROTEIN EXPRESSION; GENE-EXPRESSION; T-LYMPHOCYTES; IN-VITRO; RECEPTOR;
D O I
10.1007/s40618-023-02089-1
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The pituitary tumour microenvironment encompasses a spectrum of non-tumoural cells, such as immune, stromal or endothelial cells, as well as enzymes and signalling peptides like cytokines, chemokines and growth factors, which surround the tumour cells and may influence pituitary tumour behaviour and tumourigenic mechanisms. Recently, there has been intensive research activity in this field describing various pituitary tumour-infiltrating immune and stromal cell subpopulations, and immune- and microenvironment-related pathways. Key changes in oncological therapeutic avenues resulted in the recognition of pituitary as a target of adverse events for patients treated with immune checkpoint regulators. However, these phenomena can be turned into therapeutic advantage in severe cases of pituitary tumours. Therefore, unravelling the pituitary tumour microenvironment will allow a better understanding of the biology and behaviour of pituitary tumours and may provide further developments in terms of diagnosis and management of patients with aggressively growing or recurrent pituitary tumours.
引用
收藏
页码:1047 / 1063
页数:17
相关论文
共 50 条
  • [41] Modelling the brain tumour microenvironment
    Curd, J.
    Ashworth, J.
    Grabowska, A.
    Coyle, B.
    Merry, C.
    [J]. INTERNATIONAL JOURNAL OF EXPERIMENTAL PATHOLOGY, 2018, 99 (06) : A9 - A10
  • [42] NANOTHERAPY: TARGETING THE TUMOUR MICROENVIRONMENT
    Singh, Santosh Kumar
    Singh, Rajesh
    [J]. NATURE REVIEWS CANCER, 2022, 22 (05) : 258 - 258
  • [43] Roles of circRNAs in the tumour microenvironment
    Qiuge Zhang
    Weiwei Wang
    Quanbo Zhou
    Chen Chen
    Weitang Yuan
    Jinbo Liu
    Xiaoli Li
    Zhenqiang Sun
    [J]. Molecular Cancer, 19
  • [44] Nanotherapy: targeting the tumour microenvironment
    Santosh Kumar Singh
    Rajesh Singh
    [J]. Nature Reviews Cancer, 2022, 22 : 258 - 258
  • [45] Tumour Microenvironment in Skin Carcinogenesis
    Georgescu, Simona Roxana
    Tampa, Mircea
    Mitran, Cristina Iulia
    Mitran, Madalina Irina
    Caruntu, Constantin
    Caruntu, Ana
    Lupu, Mihai
    Matei, Clara
    Constantin, Carolina
    Neagu, Monica
    [J]. TUMOR MICROENVIRONMENTS IN ORGANS: FROM THE BRAIN TO THE SKIN - PT A, 2020, 1226 : 123 - 142
  • [46] Cellular senescence and the tumour microenvironment
    Takasugi, Masaki
    Yoshida, Yuya
    Ohtani, Naoko
    [J]. MOLECULAR ONCOLOGY, 2022, 16 (18) : 3333 - 3351
  • [47] The roles of TGFβ in the tumour microenvironment
    Michael Pickup
    Sergey Novitskiy
    Harold L. Moses
    [J]. Nature Reviews Cancer, 2013, 13 : 788 - 799
  • [48] TUMOUR MICROENVIRONMENT Driving relapse
    Alderton, Gemma K.
    [J]. NATURE REVIEWS CANCER, 2015, 15 (04) : 195 - 195
  • [49] Tumour Microenvironment and Response to Therapy
    Koukourakis, M. I.
    [J]. PUBLIC HEALTH GENOMICS, 2016, 19 : 2 - 2
  • [50] Tumour microenvironment - Remodelling resistance
    Alderton, Gemma
    [J]. NATURE REVIEWS CANCER, 2007, 7 (01) : 7 - 7